Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; and VECTOR plasma-enhanced CVD products. It also provides SPEED gapfill high-density plasma chemical vapor deposition products; and Striker single-wafer atomic layer deposition products for dielectric film solutions. In addition, the company offers Flex for dielectric etch applications; Vantex, a dielectric etch system that provides RF technology and repeatable wafer-to-wafer performance enabled by Equipment Intelligence solutions; Kiyo for conductor etch applications; Syndion for through-silicon via etch applications; and Versys metal products for metal etch processes. Further, it provides Coronus bevel clean products to enhance die yield; and Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications. The company sells its products in the United States, China, Europe, Japan, Korea, Southeast Asia, and Taiwan. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.

Lam Research Corporation

In a report released today, Vijay Rakesh from Mizuho Securities reiterated a Buy rating on Lam Research, with a price target of $365.00. According ...

New Buy Rating for Lam Research (LRCX), the Technology Giant

Bernstein analyst Stacy Rasgon maintained a Buy rating on Lam Research today and set a price target of $385.00. Rasgon covers the Technology sector...

Insiders have been trading these 5 stocks: (($GME)), (($LRCX)), (($OKLO)), (($DOCU)) and (($WDC)). Here is a breakdown of their recent trades and t...

GameStop, Lam Research, Oklo, DocuSign, Western Digital Insider Moves

Lam Research Corp ($LRCX) announced an update on their ongoing clinical study. The study “Prospective Evaluation of Anterior Aesthetic Rib Cage Rem...

New Chest Remodeling Study Signals Fresh Momentum in Aesthetic Surgery Market

Lam Research Corp ($LRCX) announced an update on their ongoing clinical study. The study “Prospective Stratified Randomized Four-Group Study of Cab...

Flight Risk, Vein Health, and Stocks: What a New Compression Study Means for Investors

Lam Research Corp ($LRCX) announced an update on their ongoing clinical study. Lam Research Corp (LRCX) has backed a new randomized clinical study ...

Lam Research Backs Imaging‑Guided Surgery Trial With Emerging Investor Upside

Lam Research Corp ($LRCX) announced an update on their ongoing clinical study. This study, titled “Prospective Stage-Stratified Histopathologic Stu...

Clinical Study Spotlight: How New Filler Safety Research Could Shape Investor Risk

Lam Research Corp ($LRCX) announced an update on their ongoing clinical study. The new clinical imaging study backed by Research Inc, a unit tied t...

Lam Research-Linked Imaging Study Targets Safer Filler Removal and Long-Term Value

Lam Research Corp ($LRCX) announced an update on their ongoing clinical study. Lam Research Corp (LRCX) is backing a new study called “Prospective ...

Lam Research Backs Structured MRI Study Aiming to Sharpen Surgical Planning

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on UiPath (PATH), Manhattan Associates (MANH) and Lam...

Analysts Have Conflicting Sentiments on These Technology Companies: UiPath (PATH), Manhattan Associates (MANH) and Lam Research (LRCX)

TipRanks’ ETF&nbsp;AI&nbsp;Analyst has an Outperform rating on the Vanguard Growth ETF&nbsp;($VUG), JPMorgan Equity Premium Income ETF&nbsp;($JEPI)...

3 Best ETFs to Buy with 10%+ Upside Potential, According to the AI Analyst

In a report released yesterday, Stacy Rasgon from Bernstein maintained a Buy rating on Lam Research, with a price target of $385.00. The company’s ...

Lam Research (LRCX): New Buy Recommendation for This Technology Giant

The company’s financial results have been strong due to the AI buildout. 


	A	B	C	D
1	Symbol	Price	Change	Volume
2	LRCX	$307.16	-0.04%	7.55M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	LRCX	$307.16	-0.0%	7.55M
3
4
5
6

LRCX

Get Lam Research Corporation Data in Excel

Get Lam Research Corporation Data in Excel